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Abstract 
Background: Underweight, overweight, and obesity at diagnosis may all worsen 
prognosis in childhood acute lymphoblastic leukaemia (ALL) but no studies have 
estimated prevalence of unhealthy weight status at diagnosis in large representative 
samples using contemporary definitions of weight status based on BMI for age. 
Methods:  Retrospective study which aimed to estimate prevalence of underweight, 
overweight, and obesity at diagnosis for patients with childhood ALL on three 
successive UK treatment trials: UKALL X (1985-1990, n 1033), UKALL XI  (1990-
1997, n 2031), UKALL 97/ 99 (1997-2002, n 898) .The BMI for age  was used to 
define weight status with both UK 1990 BMI for age reference data and the Cole-
International Obesity Task Force (IOTF) definitions.  
Results: Prevalence of underweight was 6% in the most recent trial for which data 
were available. Prevalence of overweight and obesity was 35% in the most recent trial 
when expressed using Cole-IOTF definitions; 41% when expressed relative to UK 
1990 reference data. 
Conclusions: Even with highly conservative estimates >40% of all UK patients with 
ALL were underweight, overweight, or obese  at diagnosis in the most recent trial for 
which UK data are available (UKALL 97/99, 1997-2002). 
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Introduction 
Underweight, overweight, and obesity have adverse short and long-term health effects 
for children and adolescents (Reilly et al 2003; Reilly and Kelly 2011; Pelletier et al 
2003). Moreover, both underweight and obesity at diagnosis of childhood acute 
lymphoblastic leukaemia (ALL) appear to have disease-specific adverse effects in that 
they can increase risk of relapse (Lobato-Mendizabal et al 2003; Butturini et al 2007; 
Gelelete et al 2011), with similar findings in some other childhood malignancies 
(Lange et al 2005). In addition, in a number of childhood malignancies, including 
ALL, obesity is a common consequence of the disease or its treatment (Reilly 2009).  
 
Despite the clinical importance of weight status during and after diagnosis of ALL, 
prevalence estimates of weight status at diagnosis have usually been made with small 
samples, typically from samples of patients from single centres. Prevalence estimates 
for underweight, overweight, and obesity are not available for large nationally 
representative samples of patients. In addition, older studies generally did not base 
their prevalence estimates on well- established definitions of weight status (Reilly 
2010) using the BMI for age (Cole et al 2000; Cole et al 2007; Cole et al 1995; Reilly 
et al 2010), some of which became available only recently, e.g. the definition of 
underweight from Cole et al (2007). Anonymised national trial data are available for 
patients with childhood ALL in the UK, and almost all patients enter these trials, so 
trials provide an excellent opportunity to estimate prevalence of underweight, 
overweight, and obesity for the entire patient population. The primary aim of the 
present study was therefore to describe weight status at diagnosis of ALL (typical age 
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of diagnosis is around age 4 years), using contemporary and recently-established 
definitions. 
Methods 
Study participants 
The present study was based on clinic measures of weight and height of all patients at 
entry onto the trial protocol from successive UKALL national treatment trials, which 
covered the period 1985-2002: UKALL X (1985-1990), UKALL XI (1990-1997), and 
UKALL 97/99 (1997-2002). Since 2002, patient weight and height have no longer 
been routinely measured and recorded at diagnosis of ALL in the UK: no national 
estimates of the prevalence of unhealthy weight status are possible beyond 2002. The 
Clinical Trials Service Unit, Oxford, provided the data used in the present study, in 
anonymised form.  
 
Definitions of weight status categories  
Clinic measures of weight and height were recorded to 0.1kg and 0.1cm respectively. 
These measures were used to calculate the body mass index, BMI. Internationally 
accepted definitions of child and adolescent underweight (‘thinness’; Cole et al 2007), 
overweight, and obesity (Cole et al 2000) were used: these are conceptually 
equivalent to adult BMI cut-offs for underweight, overweight, and obesity. 
International definitions of weight status were chosen for the present study because 
they are widely used in research, and are particularly suitable for  between-study and 
international comparisons. Prevalence estimates for overweight and obesity were also 
generated using UK BMI population reference data from 1990 (Cole et al 1995; 
Reilly 2010), with overweight defined as a BMI between the 85
th
 and 94
th
 percentiles  
and obesity >95
th
 percentile. The BMI for age definitions of overweight and obesity 
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based on UK 1990 population reference data are used widely in the UK, and can be 
applied to a wider age range than the Cole et al definitions based on BMI for age, 
though no clear, evidence-based, definition of underweight exists with the UK 1990 
BMI reference data. Use of UK national reference data for BMI has higher diagnostic 
accuracy for obesity (higher sensitivity for the detection of excessively fat children) 
than use of the international definitions (Reilly et al 2000; Reilly et al 2010), and has 
equal sensitivity for detection of excessive fatness in boys and girls (in contrast to use 
of Cole et al definitions in UK children; Reilly et al 2000).    
 
Statistical analysis 
 Distributions of weight status variables were not normal, and so non-parametric tests 
were used, and non-parametric summary statistics are provided. Differences in the 
prevalence of underweight, overweight, and obesity between boys and girls were not 
significant, and so prevalence estimates have been presented with data combined. 
Secular trends in median BMI Z score across the three trials were tested for 
significance using a Kruskal Wallis test. Secular trends in the  prevalence of 
underweight, overweight, and obesity across the three trials were tested for 
significance using a Chi Square Test for Trend. Minitab software version16.1.1 and 
Medcalc software version 11.5.0.0 were used for these statistical analyses. 
 
 
 
 
 
 
 6 
 
 
Results 
Characteristics of study samples are shown in Table 1.  
 
 
Prevalence of underweight was 19.4% in UKALL X (1985-1990), 16.0% in UKALL 
XI (1990-1997), and 5.8% in UKALL 97/99 (1997-2002). The secular trend in 
prevalence of underweight between the three trials was statistically significant (p< 
0.0001). Prevalence of overweight and obesity (combined) using the Cole-
International Obesity Task Force definitions (table 2) was 10.2% in UKALL X, 
13.1% in UKALL XI, and 34.5% in UKALL 97/99.The secular trend in prevalence of 
overweight and obesity between the three trials was statistically significant (p< 
0.0001). 
 
Prevalence of overweight and obesity (combined) using UK population reference data 
was 13.3% in UKALL X, 18.2% in UKALL XI, and 40.9% in UKALL 97/99 (Table 
2). The secular trend in prevalence of overweight and obesity between the three trials 
was statistically significant (p< 0.0001).  
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Discussion 
The present study demonstrates that in the UK >40% of all patients with ALL were 
underweight, overweight, or obese at diagnosis using the most recent UK dataset 
available (from the trial which ended in 2002) .  No estimates of the prevalence of 
underweight, overweight, and obesity have previously been available from nationally 
representative samples of patients using the currently recommended definitions of 
weight status based on BMI for age. It is important to note that our prevalence 
estimates were conservative. The BMI-based definitions of obesity, at best,  have 
moderate sensitivity for detection of excessively fat individuals, with a low false 
positive rate but a moderately high false negative rate, both in the general population 
of children (Reilly 2010) and in those with malignancy (Warner et al 1997; Aldhafiri 
et al 2012). The Cole-IOTF definitions are particularly conservative (Reilly 2010; 
Reilly et al 2010). In addition, children with ALL in the UK experience substantial 
excessive weight gain during and after therapy (Reilly 2009), so the estimates of 
prevalence of obesity made in the present study are  also conservative because they 
are based on measures made at diagnosis rather than after therapy.  
 
The implications of the age of the data available to the present study are worth 
considering. The last data used in this retrospective study are now ten years old, and 
routine measurement and recording of patient weight and height at diagnosis (before 
induction therapy) in the UK was abandoned a decade ago when the algorithm to 
estimate body surface area (to calculate drug dosage) was changed. This means that 
no more recent prevalence data from national samples are available in the UK. 
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Continued national surveillance of weight status of patients with ALL, with 
anonymised central data collection as used in the present study, has become 
impractical. The extent to which the prevalence estimates from the present study 
‘matter’ today will depend to a large extent on secular trends in underweight, 
overweight, and obesity in the last 10 years. A dramatic increase in the prevalence of 
childhood obesity occurred in the general population in the UK between the mid- 
1980’s until the late 1990’s (Reilly and Dorosty 1999), and the present study findings 
were consistent with these population-wide trends. Childhood obesity prevalence in 
the UK has continued to increase over the past 10 years, but the rate of increase seems 
to have slowed recently (Stamatakis et al 2010). It  seems probable that the prevalence  
of obesity from more contemporary samples of patients with ALL at diagnosis would 
be at least as high as those reported in the present study. Secular trends in 
underweight are not available for the UK as far as we are aware, and the definition of 
underweight used in the present study has emerged only relatively recently (Cole et al 
2007). 
 
In the absence of formal anthropometric screening for unhealthy weight status, few 
patients who have unhealthy weight status are identified  by experienced 
paediatricians, paediatric dietitians, paediatric nurses
 
(Cross et al 1995; Smith et al 
2008) and parents (Parry et al 2008). Identification of both underweight and 
overweight/obesity at diagnosis of ALL should be relatively straightforward using the 
BMI in conjunction with widely available centile charts
 
(Reilly 2010), but there 
remains resistance to using such charts routinely in paediatric practice, for reasons 
which have not been explored fully (Flower et al 2007). There is increasing evidence 
that paediatric nutritional screening tools are valid, reliable, and practical 
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(Gerasimidis et al 2010;  Secker and Jeejeebhoy 2007; Hulst et al 2010) and these 
could also be considered in future management of ALL. Further research will be 
required to identify how and whether to establish nutritional assessment within 
routine management of childhood ALL. 
 
 
In summary, the present study suggests that underweight, overweight, and obesity are 
likely to be very common at diagnosis in childhood ALL in the UK.  
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Table 1 Characteristics of study participants at diagnosis in three UK ALL 
trials, 1985-2002, median (IQR)   
  UKALLX 
n= 1033 (774 
boys) 
UKALL XI 
n= 2031 (1153 boys) 
UKALL 97/99 
n= 898 (488 boys) 
Age y 
 
4.5 ( 2.9, 8.1) 4.5 ( 2.5, 7.5) 4.5 (3.5,7.5) 
BMI Z score* 
 
-0.28 (-1.06, 0.47) -0.10 (-0.82, 0.77) 0.78 (-0.18, 1.52)
†
 
Height Z 
score* 
 
0.10 (-0.67, 0.78) 0.17 (-0.66, 1.01) 0.24 (-0.66, 1.02) 
*Z scores expressed relative to UK 1990 reference data using open access software. 
† 
Significant difference in median BMI Z score across the three trials (Kruskal-Wallis 
test, P< 0.0001) 
 
Table 2 Prevalence % (n) of weight status categories at diagnosis in three 
UKALL trials , 1985-2002 
Definition and  
Reference Data 
Weight status UKALLX 
% (n) 
UKALL XI 
% (n) 
UKALL 97/99 
% (n) 
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Cole et al/ 
IOTF*  
International 
Definitions
 
Underweight
†
 19.4 (178) 
 
16.0 (301) 5.8 (49) 
Healthy weight
†
 70.3 (645) 70.9 (1330) 59.7 (506) 
 
Overweight and obese
†
 10.2 (94) 13.1 (246) 34.5 (293) 
 
 
Definition 
based on 
national 
reference data 
 
 
UK 1990 
 
 
 
 
 
 
 
 
 
Healthy weight
†
  
 
 
 
 
 
 
 
86.6 (895) 
 
 
 
 
 
 
81.6 (1657) 
 
 
 
 
 
 
59.1 (531) 
Overweight and obese
† 
 
 
13.3 (138) 18.2 (374) 40.9 (367) 
*  IOTF; International Obesity Task Force. 
†  
Test for secular trend across the three 
trials significant (p< 0.0001) 
 
 
 
